The present application relates to novel substituted phenylacetate and phenylpropane amides, to methods for producing same, to the use thereof alone or in combination for the treatment and/or prevention of diseases, and to the use thereof for producing pharmaceuticals for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases.